International Journal of Nanomedicine,
Journal Year:
2025,
Volume and Issue:
Volume 20, P. 2371 - 2394
Published: Feb. 1, 2025
Lung
cancer
is
the
leading
cause
of
cancer-related
mortality
globally,
with
non-small
cell
lung
(NSCLC)
constituting
85%
cases.
Immune
checkpoint
inhibitors
(ICIs)
represented
by
anti-programmed
death
protein
1
(PD-1)/
programmed
ligand
(PD-L1)
have
emerged
as
a
promising
frontier
in
treatment,
effectively
extending
survival
patients
NSCLC.
However,
efficacy
ICIs
exhibits
significant
variability
across
diverse
patient
populations,
substantial
proportion
showing
poor
responsiveness
and
acquired
resistance
those
initially
responsive
to
treatments.
With
advancement
nanotechnology,
nanoparticles
offer
unique
advantages
tumor
immunotherapy,
including
high
permeability
prolonged
retention(EPR)
effects,
enhanced
drug
delivery
stability,
modulation
inflammatory
microenvironment(TME).
This
review
summarizes
mechanisms
NSCLC,
focusing
on
antigens
loss
defective
antigen
processing
presentation,
failure
T
priming,
impaired
migration
infiltration,
immunosuppressive
TME,
genetic
mutations.
Furthermore,
we
discuss
how
nanoparticles,
through
their
intrinsic
properties
such
EPR
effect,
active
targeting
shielding
self-regulatory
synergistic
can
potentiate
reverse
resistance.
In
conclusion,
serve
robust
platform
for
ICIs-based
NSCLC
therapy,
aiding
overcoming
challenges.
Materials,
Journal Year:
2022,
Volume and Issue:
15(9), P. 3355 - 3355
Published: May 7, 2022
Recent
advances
in
the
synthesis
of
metal
nanoparticles
(NPs)
have
led
to
tremendous
expansion
their
potential
applications
different
fields,
ranging
from
healthcare
research
microelectronics
and
food
packaging.
Among
approaches
for
exploiting
nanotechnology
medicine,
gold
nanomaterials
particular
been
found
as
most
promising
due
unique
advantages,
such
sensing,
image
enhancement,
delivery
agents.
Although,
first
scientific
article
on
was
presented
1857
by
Faraday,
during
last
few
years,
progress
manufacturing
these
has
taken
an
enormous
step
forward.
Due
nanoscale
counterparts
gold,
which
exhibit
distinct
properties
functionality
compared
bulk
material,
stand
out,
particular,
therapy,
imaging,
detection,
diagnostics,
precise
drug
delivery.
This
review
summarizes
current
state-of-the-art
knowledge
terms
biomedical
nanoparticles.
The
application
AuNPs
following
aspects
are
discussed:
(i)
imaging
diagnosing
specific
target;
(ii)
treatment
therapies
using
AuNPs;
(iii)
systems
with
a
carrier.
medical
here
we
either
consider
contrast
agent
computed
tomography
(CT),
or
particle
used
optical
instead
fluorophores.
Moreover,
nontoxic
feature,
gadolinium-based
agents
magnetic
resonance
shown.
tunable
size,
shape,
make
them
great
carriers
targeted
Therefore,
here,
summarize
gold-based
nanodrugs
that
FDA
approved.
Finally,
various
treat
diseases
discussed,
i.e.,
photothermal
photodynamic
immunotherapy.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(7), P. 1868 - 1868
Published: July 2, 2023
Cancer
immunotherapy
is
an
innovative
treatment
strategy
to
enhance
the
ability
of
immune
system
recognize
and
eliminate
cancer
cells.
However,
dose
limitations,
low
response
rates,
adverse
events
pose
significant
challenges.
To
address
these
gold
nanoparticles
(AuNPs)
have
been
explored
as
immunotherapeutic
drug
carriers
owing
their
stability,
surface
versatility,
excellent
optical
properties.
This
review
provides
overview
advanced
synthesis
routes
for
AuNPs
utilization
improve
precision
therapies.
The
also
emphasises
various
aspects
AuNP-based
immunotherapy,
including
loading,
targeting
strategies,
release
mechanisms.
application
combined
with
therapeutic
efficacy
are
briefly
discussed.
Overall,
we
aimed
provide
a
recent
understanding
advances,
challenges,
prospects
anticancer
applications.
Journal of Nanobiotechnology,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: Feb. 14, 2024
Abstract
Despite
recent
advancements
in
cancer
treatment,
this
disease
still
poses
a
serious
threat
to
public
health.
Vaccines
play
an
important
role
preventing
illness
by
preparing
the
body's
adaptive
and
innate
immune
responses
combat
diseases.
As
our
understanding
of
malignancies
their
connection
system
improves,
there
has
been
growing
interest
priming
fight
more
effectively
comprehensively.
One
promising
approach
involves
utilizing
nanoparticle
systems
for
antigen
delivery,
which
shown
potentiate
as
vaccines
and/or
adjuvants.
In
review,
we
comprehensively
summarized
immunological
mechanisms
while
focusing
specifically
on
applications
various
types
nanoparticles
field
immunotherapy.
By
exploring
these
breakthroughs,
hope
identify
significant
challenges
obstacles
making
nanoparticle-based
adjuvants
feasible
clinical
application.
This
review
serves
assess
breakthroughs
vaccinations
shed
light
prospects
potential
barriers.
doing
so,
aim
inspire
future
immunotherapies
that
harness
nanotechnology
deliver
effective
targeted
treatments.
Graphical
abstract
Small,
Journal Year:
2024,
Volume and Issue:
20(35)
Published: May 1, 2024
Abstract
Cancer
nanovaccines
represent
a
promising
frontier
in
cancer
immunotherapy,
utilizing
nanotechnology
to
augment
traditional
vaccine
efficacy.
This
review
comprehensively
examines
the
current
state‐of‐the‐art
nanovaccine
development,
elucidating
innovative
strategies
and
technologies
employed
their
design.
It
explores
both
preclinical
clinical
advancements,
emphasizing
key
studies
demonstrating
potential
elicit
robust
anti‐tumor
immune
responses.
The
study
encompasses
various
facets,
including
integrating
biomaterial‐based
nanocarriers
for
antigen
delivery,
adjuvant
selection,
impact
of
nanoscale
properties
on
performance.
Detailed
insights
into
complex
interplay
between
tumor
microenvironment
responses
are
provided,
highlighting
challenges
opportunities
optimizing
therapeutic
outcomes.
Additionally,
presents
thorough
analysis
ongoing
trials,
presenting
snapshot
landscape.
By
curating
latest
scientific
findings
developments,
this
aims
serve
as
comprehensive
resource
researchers
clinicians
engaged
advancing
immunotherapy.
Integrating
design
holds
immense
promise
revolutionizing
treatment
paradigms,
provides
timely
update
evolving
landscape
nanovaccines.
Acta Pharmaceutica Sinica B,
Journal Year:
2024,
Volume and Issue:
14(8), P. 3432 - 3456
Published: May 13, 2024
The
advent
of
cancer
immunotherapy
has
imparted
a
transformative
impact
on
treatment
paradigms
by
harnessing
the
power
immune
system.
However,
challenge
practical
and
precise
targeting
malignant
cells
persists.
To
address
this,
engineered
nanoparticles
(NPs)
have
emerged
as
promising
solution
for
enhancing
targeted
drug
delivery
in
immunotherapeutic
interventions,
owing
to
their
small
size,
low
immunogenicity,
ease
surface
modification.
This
comprehensive
review
delves
into
contemporary
research
at
nexus
NP
engineering
immunotherapy,
encompassing
an
extensive
spectrum
morphologies
strategies
tailored
toward
optimizing
tumor
augmenting
therapeutic
effectiveness.
Moreover,
it
underscores
mechanisms
that
NPs
leverage
bypass
numerous
obstacles
encountered
regimens
probes
combined
potential
when
co-administered
with
both
established
novel
modalities.
Finally,
evaluates
existing
limitations
platforms
which
could
shape
path
future
advancements
this
field.
ACS Nano,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 17, 2025
Since
their
inception
in
the
early
1960s,
development
and
use
of
nanoscale
materials
have
progressed
tremendously,
roles
diverse
fields
ranging
from
human
health
to
energy
electronics
are
undeniable.
The
application
nanotechnology
inventions
has
revolutionized
many
aspects
everyday
life
including
various
medical
applications
specifically
drug
delivery
systems,
maximizing
therapeutic
efficacy
contained
drugs
by
means
bioavailability
enhancement
or
minimization
adverse
effects.
In
this
review,
we
utilize
CAS
Content
Collection,
a
vast
repository
scientific
information
extracted
journal
patent
publications,
analyze
trends
nanoscience
research
relevant
an
effort
provide
comprehensive
detailed
picture
field.
We
examine
publication
landscape
area
insights
into
current
knowledge
advances
developments.
review
major
classes
nanosized
routes,
targeted
diseases.
outline
most
discussed
concepts
assess
advantages
nanocarriers.
objective
is
broad
overview
evolving
regarding
challenges,
evaluate
growth
opportunities.
merit
stems
extensive,
wide-ranging
coverage
up-to-date
information,
allowing
unmatched
breadth
analysis
in-depth
insights.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(9), P. 2349 - 2349
Published: Sept. 19, 2023
Gold
nanoparticles
(AuNPs)
have
received
great
attention
for
various
medical
applications
due
to
their
unique
physicochemical
properties.
AuNPs
with
tunable
optical
properties
in
the
visible
and
near-infrared
regions
been
utilized
a
variety
of
such
as
vitro
diagnostics,
vivo
imaging,
therapeutics.
Among
applications,
this
review
will
pay
more
recent
developments
diagnostic
therapeutic
based
on
photothermal
(PT)
effect
AuNPs.
In
particular,
PT
has
played
an
important
role
utilizing
light,
photoacoustic
photon
polymerase
chain
reaction
(PCR),
hyperthermia
therapy.
First,
we
discuss
fundamentals
detail
understand
background
For
ability
efficiently
convert
absorbed
light
energy
into
heat
generate
enhanced
acoustic
waves
can
lead
significant
enhancements
signal
intensity.
Integration
PCR
may
open
new
opportunities
technological
innovation
called
photonic
PCR,
where
is
used
enable
fast
accurate
temperature
cycling
DNA
amplification.
Additionally,
beyond
existing
thermotherapy
AuNPs,
be
further
applied
cancer
immunotherapy.
Controlled
damage
cells
triggers
immune
response,
which
useful
obtaining
better
outcomes
combination
checkpoint
inhibitors
or
vaccines.
Therefore,
examines
nanomedicine
among
understands
basic
principles,
advantages
disadvantages
each
technology,
importance
multidisciplinary
approach.
Based
this,
it
expected
that
help
current
status
development
direction
nanoparticle-based
disease
diagnosis
methods
treatment
methods,
hope
inspire
innovative
technologies.
Frontiers in Bioengineering and Biotechnology,
Journal Year:
2023,
Volume and Issue:
11
Published: March 17, 2023
Lung
cancer
is
the
major
cause
of
death
worldwide.
Cancer
immunotherapy
has
been
introduced
as
a
promising
and
effective
treatment
that
can
improve
immune
system’s
ability
to
eliminate
cells
help
establish
immunological
memory.
Nanoparticles
contribute
rapidly
evolving
field
by
simultaneously
delivering
variety
agents
target
site
tumor
microenvironment.
Nano
drug
delivery
systems
precisely
biological
pathways
be
implemented
reprogram
or
regulate
responses.
Numerous
investigations
have
conducted
employ
different
types
nanoparticles
for
lung
cancer.
Nano-based
adds
strong
tool
diverse
collection
therapies.
This
review
briefly
summarizes
remarkable
potential
opportunities
in
its
challenges.